ACI’s Pharma & Biotech Patent Litigation USA & Canada

IP partner Michael Abernathy is speaking at the American Conference Institute’s (ACI’s) 2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada. This is a three-day pharma and biotech patent litigation forum addressing developments in the United States, Canada, and the European Union, including federal updates, US Supreme Court and Unified Patent Court case law, litigation essentials, emerging technology, and ethical issues involving AI and Rule 11.

Mike will speak during the session GLP-1 Patent Litigation—Example or Outlier? The session is focused on the rapidly developing GLP-1 IP litigation landscape. Topics include assessing current GLP-1 litigation, comparing it with patent litigation elsewhere in pharma and biotech, identifying GLP-1-specific litigation practices and challenges, and considering whether GLP-1 litigation tactics will become a broader industry trend or remain an outlier.

CLE Credits

Please visit the event page for more information.